Olympus is once again embroiled in controversy following the discovery of emails that show the company pushed up the price of duodenoscopes after the deadly Carbapenem-resistant Enterobacteria outbreak at UCLA’s Ronald Reagan Medical Center, which left three dead.
Olympus unveiled the VISERA 4K UHD System.
Cairn Diagnostics launched the 13C-Spirulina Gastric Emptying Breath Test.
Zacks Investment Research upgraded EndoChoice Holdings from a “hold” rating to a “buy” rating.
Zydus Healthcare, a subsidiary of Cadila Healthcare, acquired gastrointestinal brand ‘Actibile’ from drug firm Albert David.
R. Gregory Scheible, MD, is the first physician Indiana to implant Apollo Endosurgery’s Orbera intragastric balloon in a patient using a non-surgical procedure.
Clinical Genomics recently closed a $15 million series A financing round.
GI Dynamics appointed Scott Schorer as president and CEO, effective immediately.
More articles on GI/endoscopy:
5 most read GI/endoscopy stories
What ulcerative colitis patients most want to know from their physicians
GI Dynamics names Scott Schorer CEO
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
